Q1 2025 Earnings Presentation (04/30/2025 00:00:00)
First Quarter 2025 Results
To be read in conjunction with the press release dated
Please also see important information regarding forward-looking statements and additional risks and uncertainties at the end of this presentation.
Excellent First Quarter 2025 Operating Results
-
Net and operating income(1) per diluted share of
$3.50 and$3.87 , respectively -
Net and operating retuon equity(2) of 17.4% and 17.2%, respectively
-
Combined ratio of 94.1%; combined ratio, excluding catastrophes(3), of 87.8%
-
Catastrophe losses of
$95.6 million , or 6.3 points of the combined ratio -
Net premiums written increase of 3.9%*
-
Renewal price increases(4) of 13.1% in Personal Lines, 11.1% in Core Commercial, and 8.4% in Specialty
-
Rate increases(4) of 11.8% in Personal Lines, 9.1% in Core Commercial, and 5.9% in Specialty
-
Loss and loss adjustment expense (LAE) ratio of 63.3%, 1.3 points below the prior-year quarter
-
Current accident year loss and LAE ratio, excluding catastrophes(5), of 58.3%, 1.0 point below the prior-year quarter, led by outstanding improvement in Personal Lines
-
Net investment income of
$106.1 million , up 18.3% from the prior-year quarter driven primarily by higher earned yields and higher cashflows, partially offset by slightly lower partnership income; net investment income from fixed maturities up 23.2% -
Book value per share of
$84.56 , up 6.8% fromDecember 31, 2024 , driven by strong earnings and a decrease in the unrealized loss position on the fixed maturity portfolio in the quarter(1) See information about this and other non-GAAP measures and definitions used throughout this presentation on the final pages of this document. 2
Consolidated Financial Results
Three months ended
($ in millions, except per share amounts)
March 31 ,2024
March 31 ,2025
Net income
$115.5 $128.2 Per diluted share
$3.18 $3.50 Operating income before interest expense and income taxes
$149.7 $186.4 Operating income after income taxes
$111.9 $141.8 Per diluted share
$3.08 $3.87 Book value per share
$70.22 $84.56 Book value per share, excluding net unrealized appreciation
(depreciation) on fixed maturity investments, net of tax (6)
$84.01 $92.64 Shareholders' equity
$2,522.7 $3,044.4 Debt
$783.4 $784.3 Total capital
$3,306.1 $3,828.7 Debt/total capital
23.7%
20.5%
Total assets
$14,594.1 $15,470.3 Net income retuon average equity
18.5%
17.4%
Operating income retuon average equity
15.1%
17.2%
First Quarter 2025 Underwriting Results
($ in millions)
Net premiums written and growth
↑ 4.2%
-
Combined ratio (CR) of 94.1%, 1.4 points improved from the prior-year quarter
-
Catastrophe losses of
$95.6 million , or 6.3 points, including 0.8 points of favorable CAT prior-year development, relatively in line with expectations,↑ 2.3% ↑ 5.1%
↑ 7.4% ↑ 3.9%
despite a quarter of elevated losses for the industry
$1,663.4
-
-
California wildfires accounted for approximately
-
Combined ratio, ex-CAT, of 87.8%, improved 1.7
points from the prior-year quarter, primarily driven by improvement in the current accident year loss
1Q24 2Q24 3Q24 4Q24 1Q25
CR: 95.5%
99.2%
95.5%
89.2%
94.1%
90.2%
89.7%
89.2%
89.2%
89.1%
59.3%
58.9%
58.2%
56.9%
58.3%
30.9%
30.8%
31.0%
32.3%
30.8%
1Q24
2Q24
3Q24
4Q24
1Q25
Current accident year combined ratio, ex-CAT(3)
Expense ratio(7)
Current accident year loss and LAE ratio, ex-CAT
and LAE ratio, ex-CAT, in Personal Lines
-
Prior-year reserve development, ex-CAT, was
$20.0 million , or 1.3 points, favorable, with favorability in each segment -
Expense ratio of 30.8% was a slight improvement from the prior-year quarter and approximated the company's expectations. Continue to expect a full year 2025 expense ratio of 30.5%
-
Net premiums written growth of 3.9%; expect the first quarter to be the low point for growth in the year
-
Net investment income of
$106.1 million , up 18.3% from the prior-year quarter, driven by higher earned yields and higher cashflows
-
Core Commercial Underwriting Highlights
|
Net premiums written |
|
|
from the prior-year quarter, driven by an |
|
Growth |
3.0% |
3.8% |
increase in the loss ratio |
($ in millions)
-
Combined ratio, ex-CAT, increased 4.9 points
2025
2024
Three months ended
March 31
|
Combined ratio |
93.9% |
103.4% |
CAT, increased 3.2 points from the prior-year |
|
Catastrophe ratio |
3.9% |
8.5% |
quarter, driven by elevated property large |
|
Combined ratio, ex-CAT |
90.0% |
94.9% |
losses; liability results remained consistent with |
Net premiums earned
-
Current accident year loss and LAE ratio, ex-
Prior-year development ratio (1.7)% (0.2)% Current accident year combined ratio, ex-CAT 91.7% 95.1%
Current accident year combined ratio, ex-CAT
91.7%
89.1%
91.8%
94.0%
95.1%
58.5%
55.7%
58.2%
58.9%
61.7%
33.2%
33.4%
33.6%
35.1%
33.4%
1Q24
2Q24
3Q24
4Q24
1Q25
Expense ratio
Current accident year loss and LAE ratio, ex-CAT
expectations
-
Net favorable prior-year reserve development, ex-CAT, of
$1.3 million , or 0.2 points, primarily driven by modest favorability in workers' compensation, largely offset by commercial auto
Attachments
Disclaimer



MetLife Announces New $3 Billion Share Repurchase Authorization
First Quarter 2025 Earnings Presentation
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
- School, BOCES healthcare costs up 22%, here’s why
- Healthcare cuts threaten Sullivan's reelection chances in Alaska
- Health insurance marketplace feels growing tremors from GOP cuts
More Health/Employee Benefits NewsLife Insurance News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
More Life Insurance News